CEREMARK PHARMA Trademark
Trademark Overview
On Thursday, February 1, 2024, a trademark application was filed for CEREMARK PHARMA with the United States Patent and Trademark Office. The USPTO has given the CEREMARK PHARMA trademark a serial number of 98386444. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, September 3, 2024. This trademark is owned by CereMark Pharma, LLC. The CEREMARK PHARMA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products for identifying radiological and biological markers of diseases; injectable solutions for medical purposes, namely, injectable pharmaceuticals for identifying radiological and biological markers of diseases and treating neurogenerative diseases; syringes sold with pharmaceuticals for identifying markers of diseases and treating neurodegenerative diseases
Development of pharmaceutical preparations and medicines; research and development in the field of medical and pharmaceutical preparations; research and development of vaccines and medicines
General Information
| Serial Number | 98386444 |
| Word Mark | CEREMARK PHARMA |
| Filing Date | Thursday, February 1, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, September 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 8, 2024 |
Trademark Statements
| Description of Mark | The mark consists of a stylized image of a brain oriented to the left of stacked words "CEREMARK PHARMA". |
| Goods and Services | Pharmaceutical products for identifying radiological and biological markers of diseases; injectable solutions for medical purposes, namely, injectable pharmaceuticals for identifying radiological and biological markers of diseases and treating neurogenerative diseases; syringes sold with pharmaceuticals for identifying markers of diseases and treating neurodegenerative diseases |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "PHARMA" |
| Goods and Services | Development of pharmaceutical preparations and medicines; research and development in the field of medical and pharmaceutical preparations; research and development of vaccines and medicines |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CereMark Pharma, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Wheeling, WV 26003 |
Trademark Events
| Event Date | Event Description |
| Monday, February 5, 2024 | NEW APPLICATION ENTERED |
| Friday, February 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, February 24, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, August 27, 2024 | ASSIGNED TO EXAMINER |
| Monday, September 2, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 2, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 2, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, September 2, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 2, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 18, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
